Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Sign of Johnson & Johnson in Markham, Canada.

The $8 billion punitive damages verdict Johnson & Johnson was ordered to pay a user of the company’s Risperdal drug in a Philadelphia courtroom earlier this month could be a harbinger of jurors’ growing hostility toward drug companies, legal experts said.

Charles Toutant

Charles Toutant is a litigation writer for the New Jersey Law Journal.

More from this author

Law Firms Mentioned


Product LiabilityBook

An excellent comprehensive guide for the products liability practitioner ... a must for every litigator's law library. Richard J. Phelan, Past President of t...
Get More Information


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.